Jianqing Xu

11.4k total citations
255 papers, 6.0k citations indexed

About

Jianqing Xu is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Jianqing Xu has authored 255 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Immunology, 83 papers in Virology and 79 papers in Molecular Biology. Recurrent topics in Jianqing Xu's work include HIV Research and Treatment (78 papers), Immune Cell Function and Interaction (58 papers) and Immunotherapy and Immune Responses (35 papers). Jianqing Xu is often cited by papers focused on HIV Research and Treatment (78 papers), Immune Cell Function and Interaction (58 papers) and Immunotherapy and Immune Responses (35 papers). Jianqing Xu collaborates with scholars based in China, United States and United Kingdom. Jianqing Xu's co-authors include Xiaoyan Zhang, Chao Qiu, Yanmin Wan, Jeffrey J. Gray, Chen Zhao, Longfei Ding, Franco Lori, Julianna Lisziewicz, Daisuke Kuroda and Katherine Kedzierska and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Jianqing Xu

246 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianqing Xu China 41 2.3k 1.9k 1.8k 1.3k 1.0k 255 6.0k
Arnaldo Caruso Italy 39 1.4k 0.6× 1.5k 0.8× 1.6k 0.9× 1.1k 0.8× 938 0.9× 260 5.9k
Oliver T. Keppler Germany 43 2.3k 1.0× 2.0k 1.0× 1.5k 0.9× 1.3k 1.0× 2.6k 2.5× 135 5.8k
Harm HogenEsch United States 49 2.4k 1.0× 3.0k 1.6× 1.2k 0.7× 946 0.7× 355 0.3× 166 6.8k
Tong‐Ming Fu United States 36 1.3k 0.5× 2.5k 1.3× 912 0.5× 2.3k 1.8× 901 0.9× 100 5.1k
David G. Brooks United States 48 2.3k 1.0× 4.6k 2.4× 1.2k 0.7× 1.4k 1.1× 1.3k 1.3× 120 8.4k
Maria Lina Tornesello Italy 45 2.2k 1.0× 1.4k 0.7× 757 0.4× 1.8k 1.4× 635 0.6× 184 5.9k
Alexander Ploß United States 44 1.3k 0.6× 1.7k 0.9× 1.6k 0.9× 3.4k 2.6× 637 0.6× 136 7.7k
Jan Münch Germany 45 2.3k 1.0× 2.0k 1.0× 2.6k 1.5× 1.4k 1.1× 2.8k 2.7× 182 7.3k
Alejandro B. Balazs United States 29 1.6k 0.7× 1.2k 0.6× 3.1k 1.7× 692 0.5× 925 0.9× 73 5.5k
Klaus Überla Germany 42 1.8k 0.8× 2.0k 1.0× 2.3k 1.3× 1.3k 1.0× 1.6k 1.5× 199 6.3k

Countries citing papers authored by Jianqing Xu

Since Specialization
Citations

This map shows the geographic impact of Jianqing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqing Xu more than expected).

Fields of papers citing papers by Jianqing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqing Xu. The network helps show where Jianqing Xu may publish in the future.

Co-authorship network of co-authors of Jianqing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqing Xu. A scholar is included among the top collaborators of Jianqing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqing Xu. Jianqing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Zikun, et al.. (2025). Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis. Emerging Microbes & Infections. 14(1). 2459132–2459132. 2 indexed citations
2.
Pan, Zhendong, Liangliang Jiang, Yingying Chen, et al.. (2025). Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations. Journal of Virology. 99(10). e0109925–e0109925.
3.
Xing, Man, Yihan Wang, Xinyu Wang, et al.. (2023). Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants. Journal of Virology. 97(10). e0072423–e0072423. 10 indexed citations
4.
Qiu, Tianyi, Xiang Wang, Caihong Zhu, et al.. (2023). One HA stalk topping multiple heads as a novel influenza vaccine. Emerging Microbes & Infections. 13(1). 2290838–2290838. 4 indexed citations
5.
Jia, Xiaoxiao, Brendon Y. Chua, Liyen Loh, et al.. (2021). High expression of CD38 and MHC class II on CD8 + T cells during severe influenza disease reflects bystander activation and trogocytosis. Clinical & Translational Immunology. 10(9). e1336–e1336. 16 indexed citations
6.
Zhang, Wei, Li Xu, Xiaoyan Zhang, Jianqing Xu, & Jun‐O Jin. (2020). CD8α− conventional dendritic cells control Vβ T‐cell immunity in response to Staphylococcus aureus infection in mice. Immunology. 159(4). 404–412. 5 indexed citations
7.
Srivastava, Mayank, Ying Zhang, Jian Chen, et al.. (2020). Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor. Nature Communications. 11(1). 3896–3896. 44 indexed citations
8.
Fu, Weihui, Qian He, Jian Chen, et al.. (2020). IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis. Science Signaling. 13(626). 21 indexed citations
9.
Hu, Zhidong, Ka‐Wing Wong, Ping Ji, et al.. (2017). Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice. Molecular Therapy. 25(5). 1222–1233. 45 indexed citations
10.
Chen, Jian, et al.. (2015). Short Communication: The Distribution of Potential N-Linked Glycosylation Sites in Gp120 Differs Among Major HIV-1 Subtypes Circulating in China. AIDS Research and Human Retroviruses. 32(1). 101–108. 2 indexed citations
11.
12.
Meng, Zhefeng, Ruolei Xin, Jun Sun, et al.. (2012). Five New CRF07_BC Near Full-Length Sequences Isolated from Sichuan, China. AIDS Research and Human Retroviruses. 29(1). 191–197. 5 indexed citations
13.
Wang, Wanhai, Zhefeng Meng, Mingzhe Zhou, et al.. (2011). Near Full-Length Sequence Analysis of Two New HIV Type 1 Unique (CRF01_AE/B) Recombinant Forms Among Men Who Have Sex with Men in China. AIDS Research and Human Retroviruses. 28(4). 411–417. 18 indexed citations
14.
Wan, Yanmin, Jianqing Xu, & Huanxiang Zhang. (2011). Immunogenicity of DNA vaccines encoding regulatory/accessory proteins derived from three different prevalent strains in China. Zhonghua weishengwuxue he mianyixue zazhi. 31(2). 157–161. 1 indexed citations
15.
Wan, Yanmin, Mingzhe Zhou, Zhefeng Meng, et al.. (2010). Deglycosylation of HIV-1 AE Gp140 Enhances the Capacity to Elicit Neutralizing Antibodies Against the Heterologous HIV-1 Clade. AIDS Research and Human Retroviruses. 26(5). 569–575. 5 indexed citations
16.
Wan, Yanmin, et al.. (2009). Deglycosylation or Partial Removal of HIV-1 CN54 gp140 V1/V2 Domain Enhances Env-Specific T Cells. AIDS Research and Human Retroviruses. 25(6). 607–617. 8 indexed citations
17.
Li, Shenwei, Lianxing Liu, Jianqing Xu, et al.. (2008). Truncation of cytoplasmic tail of EIAV Env increases the pathogenic necrosis. Virus Research. 133(2). 201–210. 2 indexed citations
18.
Liu, Lianxing, Yanmin Wan, Jianqing Xu, et al.. (2007). Immunogenicity Comparison between Codon Optimized HIV-1 CRF BC_07 gp140 and gp145 Vaccines. AIDS Research and Human Retroviruses. 23(11). 1396–1404. 6 indexed citations
19.
20.
Xu, Jianqing, Lucia Whitman, Franco Lori, & Julianna Lisziewicz. (2002). Short Communication: Methods of Using Interleukin 2 to Enhance HIV-Specific Immune Responses. AIDS Research and Human Retroviruses. 18(4). 289–293. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnaldo Caruso Breakdown of academic impact, for papers by Oliver T. Keppler Breakdown of academic impact, for papers by Harm HogenEsch Breakdown of academic impact, for papers by Tong‐Ming Fu Breakdown of academic impact, for papers by David G. Brooks Breakdown of academic impact, for papers by Maria Lina Tornesello Breakdown of academic impact, for papers by Alexander Ploß Breakdown of academic impact, for papers by Jan Münch Breakdown of academic impact, for papers by Alejandro B. Balazs Breakdown of academic impact, for papers by Klaus Überla
Rankless by CCL
2026